Novartis AG (NVS) Restructure Marks Break From Expansion
3/11/2014 8:53:47 AM
High quality global journalism requires investment. Please share this article with others using the link below, do not cut & paste the article. See our Ts&Cs and Copyright Policy for more detail. Email firstname.lastname@example.org to buy additional rights. It is four years since Joe Jimenez took over as chief executive of Novartis. But, in some ways, it feels as if he is only just getting started. Until last year, the American was working in the shadow of his predecessor Daniel Vasella, who stayed on as chairman after 17 years building the Swiss company into one of the world’s biggest drugmakers.
Help employers find you! Check out all the jobs and post your resume.
comments powered by